Bausch Health Companies (BHC) - חוב לטווח ארוך להון

The market trend for Bausch Health Companies (BHC) shares on the GURU.Markets platform helps assess the impact of debt load on a non-cyclical business with stable demand, where the indicator stands at 0.00. Bausch Health Companies is optimizing costs by outsourcing the production of legacy drugs to external contractors to prioritize R&D development. High physician confidence in its dermatology and ophthalmology products sustains its status as a global brand, despite past financial difficulties.

The extensive network of plants and laboratories of Bausch Health Companies (BHC) requires significant capital expenditures, making the long-term debt-to-equity ratio a key indicator of business sustainability. The ratio of liabilities with a maturity of over one year to equity demonstrates the company's ability to service loans without default risk, where a downward trend confirms a strengthening financial shield and the reliability of the market valuation.